Carcinogenesis Advance Access published online on February 12, 2006
Carcinogenesis, doi:10.1093/carcin/bgi354
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA
* To whom correspondence should be addressed. Aberrant crypt foci, the earliest neoplastic lesions of the colon, have genetic and epigenetic alterations. Loss of heterozygosity (LOH) of tumor suppressor gene loci is seen in most colon cancers, but it is not known how early in tumorigenesis this takes place. Nine microsatellite markers close to specific genes, i.e., APC (5q21), PTPRJ (11p11), p53 (17p13) and DCC (18q21), were analyzed in 32 ACF and samples of normal crypts from the same 28 patients. Six losses of heterozygosity were found in 5 of 32 ACF: 4 losses of heterozygosity were at 11p11, the location of the gene for protein tyrosine phosphatase receptor type J (PTPRJ) and of a second independent region of deletion; the others were at 5q21 and 18q21. Microsatellite instability (MSI) with markers for a single locus was found in 4 of 32 ACF. All the observed allelic alterations (LOH and MSI) were in 8 of 32 ACF. The finding of loss of heterozygosity in aberrant crypt foci with normal expressions of adenomatous polyposis coli and beta-catenin proteins suggests that loss of heterozygosity can occur very early in colon neoplasia and perhaps even before APC mutations. The finding of 3 of 4 of the losses of heterozygosity at 11p11 for PTPRJ and half of all the losses of heterozygosity in this study at PTPRJ suggest this gene plays a role early in colon neoplasia.
Received November 8, 2005
Revised January 10, 2006
Accepted January 23, 2006
CANCER BIOLOGY
Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon
Liping Luo 1,
Gong-Qing Shen 2,
Karen A. Stiffler 1,
Qing K. Wang 2,
Thomas G. Pretlow 1,
and
Theresa P. Pretlow 1 *
2 Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Theresa P. Pretlow, E-mail: theresa.pretlow{at}case.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. E. Toland, L. S. Rozek, S. Presswala, G. Rennert, and S. B. Gruber PTPRJ Haplotypes and Colorectal Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2782 - 2785. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tada, F. Kanai, Y. Tanaka, K. Tateishi, M. Ohta, Y. Asaoka, M. Seto, R. Muroyama, K. Fukai, F. Imazeki, et al. Down-Regulation of Hedgehog-Interacting Protein through Genetic and Epigenetic Alterations in Human Hepatocellular Carcinoma Clin. Cancer Res., June 15, 2008; 14(12): 3768 - 3776. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lance and S. R. Hamilton Sporadic Aberrant Crypt Foci Are Not a Surrogate Endpoint for Colorectal Adenoma Prevention Cancer Prevention Research, June 1, 2008; 1(1): 4 - 8. [Full Text] [PDF] |
||||
![]() |
M. R. De Miglio, P. Virdis, D. F. Calvisi, D. Mele, M. R. Muroni, M. Frau, F. Pinna, M. L. Tomasi, M. M. Simile, R. M. Pascale, et al. Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/{beta}-catenin pathway and progression of early lesions in the rat Carcinogenesis, November 1, 2007; 28(11): 2367 - 2374. [Abstract] [Full Text] [PDF] |
||||



